Antiviral drugs: entecavir |
Entecavir is a nucleoside analogue of guanosine with activity against the hepatitis B virus. It is registered in Australia for the treatment of chronic hepatitis B and is available through specialist centres.
Entecavir is taken orally once daily and the most common adverse effects are headache, fatigue, dizziness and nausea. Entecavir is eliminated renally and dose reduction is required in renal impairment.
Comments
Post a Comment